US Stock MarketDetailed Quotes

Zenas BioPharma (ZBIO)

Watchlist
  • 19.360
  • +0.040+0.21%
Close May 1 16:00 ET
  • 19.700
  • +0.340+1.76%
Post 18:49 ET
1.21BMarket Cap-2.29P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Zenas BioPharma (ZBIO) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
100.00%10M
0
0
0
10M
-90.00%5M
5M
0
0
0
Operating revenue
100.00%10M
--0
--0
--0
--10M
-90.00%5M
--5M
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
31.08%221.39M
17.63%71.31M
16.09%47.58M
38.94%55.16M
71.62%47.33M
118.92%168.89M
144.65%60.62M
185.09%40.98M
110.01%39.7M
44.49%27.58M
Selling and administrative expenses
79.24%53.32M
35.98%15.59M
76.79%13.18M
105.87%12.14M
151.67%12.42M
73.83%29.75M
162.92%11.47M
48.37%7.45M
47.74%5.9M
31.93%4.93M
-General and administrative expense
79.24%53.32M
35.98%15.59M
76.79%13.18M
105.87%12.14M
151.67%12.42M
73.83%29.75M
162.92%11.47M
48.37%7.45M
47.74%5.9M
31.93%4.93M
Research and development costs
20.79%168.06M
13.35%55.72M
2.60%34.4M
27.27%43.03M
54.18%34.92M
131.77%139.14M
140.75%49.16M
258.53%33.53M
126.66%33.81M
47.55%22.65M
Operating profit
-28.98%-211.39M
-28.21%-71.31M
-16.09%-47.58M
-38.94%-55.16M
-35.36%-37.33M
-503.71%-163.89M
-124.48%-55.62M
-215.05%-40.98M
-110.01%-39.7M
-44.49%-27.58M
Net non-operating interest income expense
-39.50%4.82M
7.97M
Non-operating interest income
52.40%12.15M
----
----
----
----
--7.97M
----
----
----
----
Non-operating interest expense
--7.33M
----
----
----
----
--0
----
----
----
----
Other net income (expense)
-26,492.39%-171.26M
-3,741.94%-173.85M
-264.80%-3.92M
71.59%2.96M
1,700.00%3.55M
93.34%-644K
-1,017.85%-4.53M
14,962.50%2.38M
117.01%1.73M
-1,918.18%-222K
Gain on sale of security
----
----
----
----
----
-182.00%-846K
--0
----
---152K
---694K
Special income (charges)
---171.67M
---166.67M
---5M
----
----
--0
--0
--0
----
----
-Less：Restructuring and merger&acquisition
----
----
----
----
----
--0
--0
--0
----
----
-Less:Other special charges
--171.67M
--166.67M
--5M
----
----
----
----
----
----
----
Other non- operating income (expenses)
106.44%417K
-58.59%-7.18M
-54.54%1.08M
57.70%2.96M
652.54%3.55M
-67.63%202K
-670.62%-4.53M
14,962.50%2.38M
1,421.83%1.88M
4,390.91%472K
Income before tax
-141.32%-377.82M
-360.63%-240.34M
-33.40%-51.5M
-37.46%-52.2M
-21.50%-33.78M
-325.17%-156.56M
-114.84%-52.18M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.8M
Income tax
-118.41%-79K
-75.29%106K
0
20K
-205K
42.52%429K
429K
0
0
0
Net income
-140.62%-377.74M
-357.08%-240.44M
-33.40%-51.5M
-37.51%-52.22M
-20.77%-33.57M
-322.87%-156.99M
-113.95%-52.6M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.8M
Net income continuous Operations
-140.62%-377.74M
-357.08%-240.44M
-33.40%-51.5M
-37.51%-52.22M
-20.77%-33.57M
-322.87%-156.99M
-113.95%-52.6M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.8M
Minority interest income
Net income attributable to the parent company
-140.62%-377.74M
-357.08%-240.44M
-33.40%-51.5M
-37.51%-52.22M
-20.77%-33.57M
-322.87%-156.99M
-113.95%-52.6M
-208.42%-38.61M
-30.74%-37.98M
-45.57%-27.8M
Preferred stock dividends
Other preferred stock dividends
0
Net income attributable to common stockholders
-140.62%-377.74M
-357.08%-240.44M
-33.40%-51.5M
-37.51%-52.22M
-20.77%-33.57M
-322.87%-156.99M
-113.95%-52.6M
-1,136.96%-38.61M
-30.74%-37.98M
-45.57%-27.8M
Basic earnings per share
29.02%-8.44
-260.70%-4.54
75.70%-1.22
-30.98%-1.25
-14.51%-0.8
-457.79%-11.89
10.84%-1.2587
-2,448.32%-5.02
42.78%-0.9544
36.29%-0.6986
Diluted earnings per share
29.02%-8.44
-260.70%-4.54
75.70%-1.22
-30.98%-1.25
-14.51%-0.8
-457.79%-11.89
10.84%-1.2587
-2,448.32%-5.02
42.78%-0.9544
36.29%-0.6986
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 100.00%10M00010M-90.00%5M5M000
Operating revenue 100.00%10M--0--0--0--10M-90.00%5M--5M--0--0--0
Cost of revenue
Gross profit
Operating expense 31.08%221.39M17.63%71.31M16.09%47.58M38.94%55.16M71.62%47.33M118.92%168.89M144.65%60.62M185.09%40.98M110.01%39.7M44.49%27.58M
Selling and administrative expenses 79.24%53.32M35.98%15.59M76.79%13.18M105.87%12.14M151.67%12.42M73.83%29.75M162.92%11.47M48.37%7.45M47.74%5.9M31.93%4.93M
-General and administrative expense 79.24%53.32M35.98%15.59M76.79%13.18M105.87%12.14M151.67%12.42M73.83%29.75M162.92%11.47M48.37%7.45M47.74%5.9M31.93%4.93M
Research and development costs 20.79%168.06M13.35%55.72M2.60%34.4M27.27%43.03M54.18%34.92M131.77%139.14M140.75%49.16M258.53%33.53M126.66%33.81M47.55%22.65M
Operating profit -28.98%-211.39M-28.21%-71.31M-16.09%-47.58M-38.94%-55.16M-35.36%-37.33M-503.71%-163.89M-124.48%-55.62M-215.05%-40.98M-110.01%-39.7M-44.49%-27.58M
Net non-operating interest income expense -39.50%4.82M7.97M
Non-operating interest income 52.40%12.15M------------------7.97M----------------
Non-operating interest expense --7.33M------------------0----------------
Other net income (expense) -26,492.39%-171.26M-3,741.94%-173.85M-264.80%-3.92M71.59%2.96M1,700.00%3.55M93.34%-644K-1,017.85%-4.53M14,962.50%2.38M117.01%1.73M-1,918.18%-222K
Gain on sale of security ---------------------182.00%-846K--0-------152K---694K
Special income (charges) ---171.67M---166.67M---5M----------0--0--0--------
-Less：Restructuring and merger&acquisition ----------------------0--0--0--------
-Less:Other special charges --171.67M--166.67M--5M----------------------------
Other non- operating income (expenses) 106.44%417K-58.59%-7.18M-54.54%1.08M57.70%2.96M652.54%3.55M-67.63%202K-670.62%-4.53M14,962.50%2.38M1,421.83%1.88M4,390.91%472K
Income before tax -141.32%-377.82M-360.63%-240.34M-33.40%-51.5M-37.46%-52.2M-21.50%-33.78M-325.17%-156.56M-114.84%-52.18M-208.42%-38.61M-30.74%-37.98M-45.57%-27.8M
Income tax -118.41%-79K-75.29%106K020K-205K42.52%429K429K000
Net income -140.62%-377.74M-357.08%-240.44M-33.40%-51.5M-37.51%-52.22M-20.77%-33.57M-322.87%-156.99M-113.95%-52.6M-208.42%-38.61M-30.74%-37.98M-45.57%-27.8M
Net income continuous Operations -140.62%-377.74M-357.08%-240.44M-33.40%-51.5M-37.51%-52.22M-20.77%-33.57M-322.87%-156.99M-113.95%-52.6M-208.42%-38.61M-30.74%-37.98M-45.57%-27.8M
Minority interest income
Net income attributable to the parent company -140.62%-377.74M-357.08%-240.44M-33.40%-51.5M-37.51%-52.22M-20.77%-33.57M-322.87%-156.99M-113.95%-52.6M-208.42%-38.61M-30.74%-37.98M-45.57%-27.8M
Preferred stock dividends
Other preferred stock dividends 0
Net income attributable to common stockholders -140.62%-377.74M-357.08%-240.44M-33.40%-51.5M-37.51%-52.22M-20.77%-33.57M-322.87%-156.99M-113.95%-52.6M-1,136.96%-38.61M-30.74%-37.98M-45.57%-27.8M
Basic earnings per share 29.02%-8.44-260.70%-4.5475.70%-1.22-30.98%-1.25-14.51%-0.8-457.79%-11.8910.84%-1.2587-2,448.32%-5.0242.78%-0.954436.29%-0.6986
Diluted earnings per share 29.02%-8.44-260.70%-4.5475.70%-1.22-30.98%-1.25-14.51%-0.8-457.79%-11.8910.84%-1.2587-2,448.32%-5.0242.78%-0.954436.29%-0.6986
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -